JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Leukemia

NCT06902025 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

B-ALL

Interventions

DRUG: JY231 Injection

Sponsor

He Huang